| SAAM II: simulation, analysis, and modeling software for tracer and pharmacokinetic studies PHR Barrett, BM Bell, C Cobelli, H Golde, A Schumitzky, P Vicini, ... Metabolism 47 (4), 484-492, 1998 | 517 | 1998 |
| Apolipoprotein C-III: understanding an emerging cardiovascular risk factor EMM Ooi, PHR Barrett, DC Chan, GF Watts Clinical science 114 (10), 611-624, 2008 | 432 | 2008 |
| Waist circumference, waist-to-hip ratio and body mass index as predictors of adipose tissue compartments in men DC Chan, GF Watts, PHR Barrett, V Burke Qjm 96 (6), 441-447, 2003 | 416 | 2003 |
| Randomized controlled trial of the effect of n–3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity DC Chan, GF Watts, TA Mori, PHR Barrett, TG Redgrave, LJ Beilin The American journal of clinical nutrition 77 (2), 300-307, 2003 | 370 | 2003 |
| The role of the LDL receptor in apolipoprotein B secretion J Twisk, DL Gillian-Daniel, A Tebon, L Wang, PHR Barrett, AD Attie The Journal of clinical investigation 105 (4), 521-532, 2000 | 307 | 2000 |
| Lipid Disorders and Mutations in the APOB Gene AJ Whitfield, PHR Barrett, FM van Bockxmeer, JR Burnett Clinical chemistry 50 (10), 1725-1732, 2004 | 303 | 2004 |
| Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo AI in healthy men B Lamarche, KD Uffelman, A Carpentier, JS Cohn, G Steiner, PH Barrett, ... The Journal of clinical investigation 103 (8), 1191-1199, 1999 | 288 | 1999 |
| Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome GF Watts, PHR Barrett, J Ji, AP Serone, DC Chan, KD Croft, F Loehrer, ... Diabetes 52 (3), 803-811, 2003 | 248 | 2003 |
| Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia MS Farvid, TWK Ng, DC Chan, PHR Barrett, GF Watts Diabetes, obesity and metabolism 7 (4), 406-413, 2005 | 240 | 2005 |
| Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesity DC Chan, GF Watts, PHR Barrett, LJ Beilin, TA Mori Clinical Chemistry 48 (6), 877-883, 2002 | 228 | 2002 |
| Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia DC Chan, GF Watts, PHR Barrett, LJ Beilin, TG Redgrave, TA Mori Diabetes 51 (8), 2377-2386, 2002 | 205 | 2002 |
| Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) AI and ApoB-containing lipoproteins S Lamon-Fava, MR Diffenderfer, PHR Barrett, A Buchsbaum, M Nyaku, ... Arteriosclerosis, thrombosis, and vascular biology 28 (9), 1672-1678, 2008 | 192 | 2008 |
| Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet DC Chan, GF Watts, SK Gan, EMM Ooi, PHR Barrett Diabetes Care 33 (5), 1134-1139, 2010 | 183 | 2010 |
| Dyslipidemia in visceral obesity: mechanisms, implications, and therapy DC Chan, HPR Barrett, GF Watts American Journal of Cardiovascular Drugs 4, 227-246, 2004 | 177 | 2004 |
| Personal model‐assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD A Mardinoglu, E Bjornson, C Zhang, M Klevstig, S Söderlund, M Ståhlman, ... Molecular systems biology 13 (3), 916, 2017 | 175 | 2017 |
| Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women NR Matthan, FK Welty, PHR Barrett, C Harausz, GG Dolnikowski, ... Arteriosclerosis, Thrombosis, and Vascular Biology 24 (6), 1092-1097, 2004 | 174 | 2004 |
| Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration DC Chan, GF Watts, TG Redgrave, TA Mori, PHR Barrett Metabolism-Clinical and Experimental 51 (8), 1041-1046, 2002 | 172 | 2002 |
| Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism DC Chan, GF Watts, TWK Ng, Y Uchida, N Sakai, S Yamashita, ... Clinical chemistry 51 (3), 578-585, 2005 | 168 | 2005 |
| Effect of dietary fatty acids on human lipoprotein metabolism: a comprehensive update EMM Ooi, GF Watts, TWK Ng, PHR Barrett Nutrients 7 (6), 4416-4425, 2015 | 157 | 2015 |
| Controlled study of the effect of proprotein convertase subtilisin-kexin type 9 inhibition with evolocumab on lipoprotein (a) particle kinetics GF Watts, DC Chan, R Somaratne, SM Wasserman, R Scott, ... European heart journal 39 (27), 2577-2585, 2018 | 151 | 2018 |
